Sign up to save your podcasts
Or
Share Gastrointestinal dysfunction in Parkinson’s disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gastrointestinal dysfunction in Parkinson’s disease
Brought to US Healthcare professionals by Acorda Therapeutics
Dr. Ron Pfeiffer, Professor, Department of Neurology, Oregon Health & Science University, discusses gastrointestinal complications in patients with Parkinson’s disease.
Brudek T, et al. J Parkinsons Dis. 2019;9(s2):S331-S344., Camci G, et al. J clin neurol. 2016;12(2):147-150., Chaing HL, et al. J Mov Disord. 2019;12(2):67-83., Chandra R, et al. JCI Insight. 2017;2(12)., Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16., Deleu D, et al. Clin Pharmacokinet.
2002;41(4):261-309., Dutta SK, et al. J Neurogastroenterol Motil. 2019;25(3):363-376., Fasano A, et al. Lancet Neurol. 2015;14(6):625-639., Goetze O, et al. Neurogastroenterol Motil. 2006;18(5):369-375., Keshavarzian A, et al. Prog Brain Res. 2020;252:357-450., Killinger B, et al. J Parkinsons Dis 2019;
9(Suppl 2): S345–S358., Liddle RA, et al. Brain Res. 2018;1693(Pt B):201-206., Maini Rekdal V, et al. Science. 2019;364(6445)., Marsden CD, et al. Lancet. 1976;1(7954):292-296., McGee DJ, et al. J Parkinsons Dis. 2018;8(3):367-374., Miraglia F, et al. Cells. 2019;8(3)., Nyholm D, et al. Opin Drug Metab Toxicol. 2008;4(2):193-203., Pfeiffer RF, et al. Parkinsonism Relat Disord. 2020;S1353-
8020(20)30110-3., Pfeiffer RF, et al. Curr Treat Options Neurol. 2018;20(12):54., Rietdijk CD, et al. Front Neurol. 2017;8(37)., Safirstein BE, et al. Clin Ther. 2020;42(6):1034-1046., Svensson E, et al. Mov Disord. 2016;31(12):1918-1922., Unger MM, et al. Parkinsonism Relat Disord. 2016;32:66-72.
View all episodes
By managingoff
5
11 ratings
Brought to US Healthcare professionals by Acorda Therapeutics
Dr. Ron Pfeiffer, Professor, Department of Neurology, Oregon Health & Science University, discusses gastrointestinal complications in patients with Parkinson’s disease.
Brudek T, et al. J Parkinsons Dis. 2019;9(s2):S331-S344., Camci G, et al. J clin neurol. 2016;12(2):147-150., Chaing HL, et al. J Mov Disord. 2019;12(2):67-83., Chandra R, et al. JCI Insight. 2017;2(12)., Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16., Deleu D, et al. Clin Pharmacokinet.
2002;41(4):261-309., Dutta SK, et al. J Neurogastroenterol Motil. 2019;25(3):363-376., Fasano A, et al. Lancet Neurol. 2015;14(6):625-639., Goetze O, et al. Neurogastroenterol Motil. 2006;18(5):369-375., Keshavarzian A, et al. Prog Brain Res. 2020;252:357-450., Killinger B, et al. J Parkinsons Dis 2019;
9(Suppl 2): S345–S358., Liddle RA, et al. Brain Res. 2018;1693(Pt B):201-206., Maini Rekdal V, et al. Science. 2019;364(6445)., Marsden CD, et al. Lancet. 1976;1(7954):292-296., McGee DJ, et al. J Parkinsons Dis. 2018;8(3):367-374., Miraglia F, et al. Cells. 2019;8(3)., Nyholm D, et al. Opin Drug Metab Toxicol. 2008;4(2):193-203., Pfeiffer RF, et al. Parkinsonism Relat Disord. 2020;S1353-
8020(20)30110-3., Pfeiffer RF, et al. Curr Treat Options Neurol. 2018;20(12):54., Rietdijk CD, et al. Front Neurol. 2017;8(37)., Safirstein BE, et al. Clin Ther. 2020;42(6):1034-1046., Svensson E, et al. Mov Disord. 2016;31(12):1918-1922., Unger MM, et al. Parkinsonism Relat Disord. 2016;32:66-72.